wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35743878-A95D309B-4925-41E9-AC18-EE9E40CA3C3B
Q35743878-A95D309B-4925-41E9-AC18-EE9E40CA3C3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35743878-A95D309B-4925-41E9-AC18-EE9E40CA3C3B
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
P2860
Q35743878-A95D309B-4925-41E9-AC18-EE9E40CA3C3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35743878-A95D309B-4925-41E9-AC18-EE9E40CA3C3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ffcdbcf96177e3570aff88d29c0138cd52517ca0
P2860
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.